Obsidian Therapeutics, Inc. (OBX) is in Healthcare, Biotechnology, based in United States, listed on NasdaqCM. Market cap 756.10M USD. 52-week range 12.07 to 49.97 USD. Data as of 2026-10-09.
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing ...